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Background: Both airflow limitation and obstructive sleep apnea-hypopnea syndrome 
(OSAHS)-related symptoms are most prevalent in the elderly population. Previous studies 
revealed significant associations between OSAHS-related symptoms and obstructive airway 
diseases in the general population. However, other studies showed that the frequency of 
OSAHS-related symptoms in patients with obstructive airway diseases decreases after the 
age of 60 and older.
Aims: To investigate the prevalence of OSAHS-related symptoms (snoring, breathing pauses, 
and excessive daytime sleepiness [EDS]) and their relations to airflow limitation, for people 
over 65 years old.
Methods: A full screening spirometry program was performed in a total of 490 aging par-
ticipants (mean age 77.5 years – range 65–98) who were attending 16 home care settings in 
central Greece. Airflow limitation was assessed according to the Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) spirometric criteria (FEV
1
/FVC ,70%). The Berlin Ques-
tionnaire and the Epworth Sleepiness Scale were used to screen individuals for OSAHS-related 
symptoms. Bivariate associations were described using odds ratio (OR) with 95% confidence 
intervals (CI).
Results: Airflow limitation prevalence was 17.1% (male 24.2% and female 9.9%) and was 
strongly related to male gender and smoking status. The prevalence rates of frequent snoring, 
breathing pauses, and EDS were 28.1%, 12.9%, and 11.6%, respectively. However, participants 
with airflow limitation were less likely to report breathing pauses, frequent snoring, EDS, and 
obesity. Finally, frequent snoring was significantly more common in males than females.
Conclusion: This study revealed decreased frequency of OSAHS-related symptoms in partici-
pants with airflow limitation suggesting that OSAHS-related symptoms and airflow limitation 
are not related in our elderly population.
Keywords: sleep apnea syndrome, obstructive airway diseases, excessive daytime sleepiness, 
snoring
Introduction
The obstructive sleep apnea-hypopnea syndrome (OSAHS) is a condition characterized 
by different types of respiratory events that occur during sleep.1 Clinically, OSAHS is 
defined by the occurrence of excessive daytime sleepiness (EDS), loud snoring, and 
witnessed breathing pauses (at least five events of apneas/hypopneas per hour of sleep). 
Worldwide, the prevalence of the syndrome ranges between 30% and 80% for people 
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aged 65 years and over,2 compared to 2%–4% in middle-
aged population.3 Recent studies have shown that OSAHS 
has been associated with a number of chronic diseases, 
such as cardiovascular disease (CVD) and hypertension.4 
In addition, associations between OSAHS and increased 
likelihood of vehicle accidents, mainly due to daytime hyper 
somnolence,5,6 and obese women after menopause have also 
been published.7
It has been suggested that elderly patients attending pri-
mary care often have higher prevalence rates of hypertension, 
obesity, and obstructive airway diseases including chronic 
obstructive pulmonary disease (COPD) and asthma that are 
associated with sleep apnea syndrome.8,9 In the international 
literature, an association of snoring and breathing pauses in 
the elderly population with obstructive airway disease has 
also been reported,10,11 but the true figures of this association 
are conflicting.12,13 In Greece, only one study has investigated 
the frequency of OSAHS-related symptoms in patients with 
obstructive airway diseases using a spirometry program in the 
general population,14 and no study was performed on elderly 
people receiving home care.
Consequently the purpose of this study was to estimate 
the prevalence of OSAHS-related symptoms in an elderly 
population aged over 65 years old receiving home care in 
central Greece, and to determine whether these symptoms 
are related to airflow limitation. The secondary aims of the 
present study were to investigate a possible epidemiological 
association and/or differences of OSAHS-related symptoms 
between males and females with respect to age group and a 
history of certain comorbidities and obesity.
Material and methods
study design
This cross-sectional study was conducted in 16 home care 
settings in Thessaly, central Greece, during a 6-month 
period (January to June 2010). Home care settings pro-
vide social, nursing, and medical care to their registered 
members. These members are mainly elderly people over 
65 years old, with a disadvantaged social status and/or a 
poor family support. Following an invitation by the local 
municipality authorities, this study recruited these elderly 
members to participate in a door-to-door screening 
OSAHS and spirometry program. A total of 518 elderly who 
attended home care settings in Thessaly were approached 
and 490 of them (response rate 94.5%) completed the study 
questionnaires and subsequently underwent spirometry 
measurement after their informed consent. None of the par-
ticipants had a prior diagnosis for OSAHS.
study analysis
OSAHS-related symptoms were assessed using the Berlin 
Questionnaire, which has been widely used in primary care 
showing high sensitivity 0.86 and specificity 0.77 for a respira-
tory disturbance index (RDI .5).15 The Berlin Questionnaire 
includes questions about snoring and witnessed apneas during 
sleep (category 1), tiredness or fatigue after sleep (category 2), 
and history of hypertension and/or obesity (category 3). Patients 
present a high pre-test probability for OSAHS if their responses 
are positive in two out of the three categories.
Subjective daytime sleepiness was quantified using 
the Greek version of the Epworth Sleepiness Scale.16 The 
Epworth Sleepiness Scale summary score ranges between 0 
and 24 and a score greater than 10 is indicative of EDS.17
Obesity was defined according to the World Health 
Organization recommendations (body mass index 
[BMI] $30 kg/m2).18 History of hypertension, CVDs, 
and stroke were documented from patients’ medical files. 
Demographic data were also recorded in a structured ques-
tionnaire and included gender, age, education, occupation 
before pension, and smoking status. Two age groups were 
defined, 65–79 and more than 80 years old, following the 
current cut-point of life expectancy for the Greek population 
in the year 2009 (males 79 and females 81 years old).19
Airflow limitation diagnosis was based on spirometry. 
Spirometric tests were performed by a trained technician using 
the turbine flow spirometer (Pony FX, Cosmed, Rome, Italy), 
following the American Thoracic Society and European Respi-
ratory Society standards,20 and airflow limitation was diagnosed 
when the post-bronchodilatation ratio of FEV
1
 to FVC was 
less than 70% predicted (FEV
1
/FVC ,70%). A qualified pul-
monologist interpreted the spirometric data and made the final 
diagnosis of airflow limitation using the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) criteria.21
ethics committee
The study was conducted as a part of the clinical develop-
ment of medical interventions in primary care, and there-
fore meets the written ethical approval by the Scientific 
Council of Medical Department – University of Thessaly 
(Pr No 5740-7th/October 15, 2008). All participants gave 
informed consent, after a detailed briefing by the researchers 
for the purpose and procedures of study, while underlining 
that their participation was voluntary.
statistical analysis
Differences of prevalence rates between different patient 
groups were examined using chi-square tests and binary 
International Journal of COPD 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1113
Sleep-related symptoms and airflow limitation in the elderly
logistic regression, and presented as odds ratios (OR) with 
95% confidence interval (CI). Comparisons between continu-
ous variables were performed by Mann–Whitney U Test. For 
the evaluation of possible associations between obesity and 
OSAHS-related symptoms with respect to gender, airflow 
limitation, hypertension, CVD, and stroke, logistic regression 
was also applied. All reported P-values were two-tailed, and 
a P-value ,0.05 was considered statistically significant. Data 
were analyzed using the STATA software package (Stata-
Corp 2011. Stata Statistical Software: Release 12. StataCorp 
LP, College Station, TX, USA).
Results
The internal consistencies of the Berlin Questionnaire and 
the Epworth Sleepiness Scale (Cronbach-alpha, 0.69 and 
0.77, respectively), were considered sufficient to proceed to 
the statistical analysis.
In Table 1 we present the main participant characteristics. 
Mean age did not differ between males and females (P=0.085). 
Among the study participants, the prevalence rates of OSAHS-
related symptoms (breathing pauses, EDS, and frequent snoring) 
were 6.3%, 11.6%, and 28.1%, respectively. The frequency of 
obesity was 44.3% among the study participants.
The prevalence of airflow limitation and distribution 
of OSAHS-related symptoms between gender and age are 
presented in Table 2. A history of stroke was not different 
between the two genders (4.8% versus 5.0%, respectively, 
P=0.951). Males reported a history of CVDs more fre-
quently than females (40.7%, versus 29.3%, P,0.001), 
while for a history of hypertension the situation was reversed 
(47.6% versus 57.4%, P,0.001).
Logistic regression revealed that patients with airflow 
limitation were significantly more likely to be males (OR =2.9; 
95% CI: 1.74–4.84, P,0.001), current smokers (OR =3.76; 
CI: 1.82–7.79, P,0.001) or former smokers (OR =2.84; CI: 
1.69–4.79, P,0.001). The prevalence of airflow limitation was 
higher in non-obese compared to obese participants (19.4% 
versus 14.3%), but the difference was not statistically signifi-
cant (P=0.135). However, participants with airflow limitation 
had lower mean BMI compared to those without (28.4±4.8 
versus 29.9±5.3, P=0.034), while a significant trend towards 
decreasing prevalence of airflow limitation with increasing BMI 
was noted (χ2 test for linear trend, P=0.047). Of the participants 
finally diagnosed with airflow limitation in this study, only 25% 
had a prior diagnosis of airflow limitation.
sleep-related symptoms and obesity  
in patients with and without  
airflow limitation
Participants with airflow limitation were less likely to report 
breathing pauses (OR =0.7; 95% CI: 0.24–2.06, P=0.518), 
frequent snoring (OR =0.98; CI: 0.57–1.66, P=0.94), and 
EDS (OR =0.65; CI: 0.28–1.48, P=0.303). These findings 
were reported while participants with airflow limitation were 
also unlikely to be obese than those without (OR =0.69; CI: 
0.43–1.12, P=0.135). However, none of these associations 
were statistically significant – (Figure 1).
sleep-related symptoms and obesity  
in patients with a history of hypertension, 
CVD, and stroke
A history of hypertension was not associated with frequent 
snoring (OR =1.03; CI: 0.69–1.55, P=0.883), breathing 
pauses (OR =1.11; CI: 0.53–2.31, P=0.783), and EDS 
(OR =1.28; CI: 0.73–2.43, P=0.382). However, participants 
Table 1 Demographic data of the study participants
Characteristic N Prevalence (%)
sex 490
 Male 248 50.6
 Female 242 49.4
age (years) 77.5±6.9
 65–79 314 64.1
 $80 176 35.9
smoking status
 Current 44 9.0
 Former 138 28.2
 never 308 62.9
BMI Mean 29.7±5.3
 Obesity (BMI $30 kg/m2) 217 44.3
Osahs-related symptoms
 Breathing pausesa 31 6.3
 eDsb 57 11.6
 Frequent snoringc 130 28.1
Chronic comorbid diseases
 hypertension 257 52.4
 CVDd 172 35.1
 stroke 24 4.9
Airflow limitation (GOLD)
 (FeV1/FVC ,70%) predicted 84 17.1
 stage I ( FeV1 $80%) 25 5.1
 stage II (FeV1 50%–79%) 38 7.7
 stage III (FeV1 30%–49%) 16 3.3
 stage IV (FeV1 ,30%) 5 1.0
Notes: Prevalence was given as actual numbers of patients (n) and percentages (%). 
aPatients witnessed apnoeas “almost every day” or “3–4 times a week”; bepworth 
sleepiness scale – score (ess $10); cpatients snoring “almost every day” or 
“3–4 times a week”; dincludes congestive: heart failure, coronary artery disease, 
and arrhythmias.
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; eDs, excessive 
daytime sleepiness; gOlD, global Initiative for Chronic Obstructive lung Disease; 
Osahs, obstructive sleep apnea-hypopnea syndrome; FeV1/FVC, forced expiratory 
volume in 1 second /forced vital capacity.
International Journal of COPD 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1114
Kleisiaris et al
sleep-related symptoms and obesity 
between genders
EDS and frequent snoring were more frequent in males than 
females (OR =1.18; CI: 0.68–2.07, P=0.544 and OR =1.70; 
CI: 1.13–2.57, P=0.012, respectively) although this difference 
was significant only for frequent snoring. However, males were 
less likely to report breathing pauses than females (OR =0.9; 
CI: 0.44–1.88, P=0.798). These differences were observed 
despite the fact that males were less likely to be obese than 
females (OR =0.47; CI: 0.32–0.67, P,0.001) – Figure 2.
sleep-related symptoms and obesity 
between age groups
Participants aged 80 years old and over were significantly 
more likely to report EDS (OR =1.86; CI: 1.06–3.24, P=0.029) 
than those aged 65–79 years old, and were less likely to 
report breathing pauses and frequent snoring (OR =0.98; CI: 
0.46–2.10, P=0.958, and OR =0.77; CI: 0.50–1.90, P=0.247, 
respectively) than participants aged 65–79 years old. Also, 
older participants (80+) were less obese (OR =0.56; CI: 
0.38–0.81, P=0.003) than the younger ones – (Figure 3).
Table 2 Distribution of responses according to sex and age
Age groups Males Females
65–79 $80 Total 65–79 $80 Total
Obesity (BMI $30 kg/m2)
 Yes 58 39.7% 29 28.4% 87 35.1% 97 57.7% 33 44.6% 130 53.7%
 no 88 60.3% 73 71.6% 161 64.9% 71 42.3% 41 55.4% 112 46.3%
Breathing pauses
 Yesa 8 5.5% 7 6.9% 15 6.0% 12 7.1% 4 5.4% 16 6.6%
 no 138 94.5% 95 93.1% 233 94.0% 156 92.9% 70 94.6% 226 93.4%
eDs
 ess $10 15 10.3% 16 15.7% 31 12.5% 14 8.3% 12 16.2% 26 10.7%
 ess ,9 131 89.7% 86 84.3% 217 87.5% 154 91.7% 62 83.8% 216 89.3%
Frequent snoring
 Yesb 52 35.6% 29 18.2% 81 33.1% 37 24.4% 13 18.6% 50 22.6%
 no 94 64.4% 70 81.8% 164 76.9% 115 75.6% 77 81.4% 192 77.4%
history of hypertension
 Yes 67 45.9% 51 50.0% 118 47.6% 93 55.4% 46 62.2% 139 57.4%
 no 79 54.1% 51 50.0% 130 52.4% 75 44.6% 28 37.8% 103 42.6%
history of CVD
 Yes 57 39.0% 44 43.1% 101 40.7% 48 28.6% 23 31.1% 71 29.3%
 no 89 61.0% 58 56.9% 147 59.3% 120 71.4% 51 68.9% 171 70.7%
history of stroke
 Yes 8 5.5% 4 3.9% 12 4.8% 12 7.1% 0 0.0% 12 5.0%
 no 138 94.5% 98 96.1% 236 95.2% 156 92.9% 74 100% 230 95.0%
Airflow limitation
 Yes 36 24.7% 24 23.5% 60 24.2% 12 7.1% 12 16.2% 24 9.9%
 no 110 75.3% 78 76.5% 188 75.8% 156 92.9% 62 83.8% 218 90.1%
Notes: Data were given as actual numbers of patients and percentages (%). aPatients witnessed apnoeas “almost every day” or “3–4 times a week”; bpatients snoring “almost 
every day” or “3–4 times a week”.
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; eDs, excessive daytime sleepiness; ess, epworth sleepiness scale.
with a history of hypertension were significantly more likely 
to be obese (OR =1.61; CI: 1.12–2.3, P=0.010).
No significant difference in OSAHS-related symptoms 
between patients with CVD and those without CVD was 
found. In particular, elderly patients with a history of CVD 
were less likely to report breathing pauses (OR =0.74; 
CI: 0.33–1.65, P=0.466), EDS (OR =0.92; CI: 0.51–1.64, 
P=0.77), and to be obese (OR =0.89; CI: 0.61–1.3, P=0.546), 
whereas these patients were more likely to report frequent 
snoring (OR =1.36; CI: 0.9–2.06, P=0.149) than elderly 
patients without CVD.
We also found no significant difference in OSAHS-
related symptoms between patients with stroke compared 
to those without stroke. Particularly, participants with a 
history of stroke were less likely to report frequent snoring 
(OR =0.66; CI: 0.24–1.81, P=0.442) and EDS (OR =0.68; 
CI: 0.15–2.99, P=0.607) than participants without stroke 
history. However, stroke patients were more likely to report 
breathing pauses (OR =1.37; CI: 0.31–6.11, P=0.680) and to 
be obese (OR =1.27; CI: 0.56–2.89, P=0.564) than patients 
without stroke history, but these differences were also not 
significant.
International Journal of COPD 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1115
Sleep-related symptoms and airflow limitation in the elderly
Discussion
In this cross-sectional study we found that the OSAHS-related 
symptoms did not differ between patients with and without 
airflow limitation. Particularly, the elderly participants with 
airflow limitation presented lower prevalence rates of EDS, 
breathing pauses, frequent snoring, and obesity than those 
Obesity
0.69
0.7
0.65
0.98
0 1 2 3
Breathing pauses
EDS
Frequent snoring
Figure 1 Comparisons between patients with and without airflow limitation with 
regard to Osahs-related symptoms and obesity.
Notes: an Or .1 indicates greater likelihood for patients with airflow limitation. 
Bars represent 95% (CI).
Abbreviations: Osahs, obstructive sleep apnea-hypopnea syndrome; CI, 
confidence interval; EDS, excessive daytime sleepiness; OR, odds ratio.
Obesity
0.47
0.9
1.18
1.7
0 1 2 3
Breathing pauses
EDS
Frequent snoring
Figure 2 Comparisons between male and female patients with regard to Osahs-
related symptoms and obesity.
Notes: an Or .1 indicates greater likelihood for males. Bars represent 95% (CI).
Abbreviations: Osahs, obstructive sleep apnea-hypopnea syndrome; CI, 
confidence interval; EDS, excessive daytime sleepiness; OR, odds ratio.
Obesity
0.56
0.9
1.86
0.77
0 1 2 4
Breathing pauses
EDS
Frequent snoring
3
Figure 3 Diferences between the two age groups with regard to Osahs-related 
symptoms and obesity.
Notes: an Or .1 indicates greater likelihood for people aged .80 years old. Bars 
represent 95% (CI).
Abbreviations: Osahs, obstructive sleep apnea-hypopnea syndrome; CI, 
confidence interval; EDS, excessive daytime sleepiness; OR, odds ratio.
without, whereas these associations were not significant. 
However, EDS was significantly reported more often in 
males than females, and older people aged .80 years old than 
those aged 65–79 years old, while frequent snoring was more 
prevalent in males. Finally, a history of chronic comorbidities 
was also not related to sleep-related symptoms.
The main finding of the present study was that our 
elderly population with airflow limitation was less likely 
to report OSAHS-related symptoms than the ones without 
airflow limitation, while these relations were not significant. 
In comparison to our results,14 a similar study conducted 
in the same region of Greece in the general population 
(mean age 60.7 years old), showed increased frequency of 
OSAHS-related symptoms in COPD and asthma patients, 
but the associations were significant only for COPD patients. 
Furthermore, a recent study in Iran also reported significant 
associations between airflow obstruction and high-risk for 
OSAHS in the general population, as defined by the Berlin 
Questionnaire. However, only a small percentage (13.5%) of 
the total study sample was more than 60 years old.10
Interestingly, several sleep-lab studies supply us with 
comparative explanations with regard to the occurrence 
of respiratory events of apnoeas in patients with airflow 
limitation. Specifically, the Sleep Heart Health Study22 has 
shown that the frequency of the respiratory disturbance 
index did not differ between participants with and without 
obstructive airway disease (mean age 66 years old). Similar 
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findings were reported by Bednarek et al,23 showing that in 
the general population, the prevalence of airflow obstruction 
was equal to the prevalence of OSAHS population (AHI/
RDI .5), whereas only one person over 60 years old was 
diagnosed with both conditions. Furthermore, Sharma et al, 
using both the Berlin Questionnaire and polysomnography 
data, also found that there was no association between FEV
1
% 
predicted and high-risk of OSAHS. However, the increased 
OR of OSAHS found in both, COPD and asthma patients 
were mainly linked to the presence of obesity.12
We also found no significant association between EDS and 
airflow limitation, although EDS was more frequent in elderly 
men than women and in those patients aged over 80 years old 
than those aged 65–79 years old. These results are similar to 
a previous study showing that the presence of EDS was found 
within the normal limits in patients with chronic hypoxemia 
and COPD.24 In our study, frequent snoring was not related to 
airflow limitation, in contrast with latest studies.10–14 However, 
data from the Sleep Heart Health Study revealed that habitual 
snoring prevalence decreases as age increases from 50 to 60 
and finally to 70 years old and over, and frequent snoring 
prevalence also decreases after the age of 65.13–22 In our study, 
older patients (.80 years old) reported less frequent snoring 
than those of the first age group (65–79 years old), but this 
difference was not significant. Previous studies in Australian 
men and Italian women also found no association between 
frequent snoring and age, while differences were found due 
to obesity.25,26 Since our study population is older compared to 
other studies, this plausibly explains our decreased prevalence 
rates of OSAHS-related symptoms in patients with airflow 
limitation. Numerous community large-population studies,12–22 
reported that as age increases, the magnitude of these associa-
tions for snoring and breathing pauses decreases and becomes 
less significant after the age of 60 and/or cease to exist.13,27,28
It is widely recognized that, OSAHS has been associated 
with CVD, hypertension, and obesity.1–4 However, we did not 
find significant associations between these comorbidities and 
sleep-related symptoms, despite the fact that elderly patients 
with a history of hypertension were more likely to report frequent 
snoring, breathing pauses, and EDS. Our data are in contrast 
with Karachaliou et al’s findings which showed that hyperten-
sion was strongly associated with EDS and frequent snoring, 
whereas hypertension was not related to breathing pauses.14 
In our study we showed that hypertension was associated 
only with obesity. This result is in agreement with a previous 
brief review which reported that at least part of the association 
between obesity and hypertension was related to the presence 
of sleep apnea syndrome.9 Moreover, we found that patients 
with a history of CVD and stroke were less likely to present 
frequent snoring and EDS. These findings are almost similar to 
the findings of a Honolulu Heart Program cohort study by Foley 
et al29 who reported that the diagnoses of CVD and stroke were 
not associated with habitual snoring, while daytime sleepiness 
was associated with heart disease. They also found a relation 
between age and EDS and their ORs were similar to ours. In the 
present study, patients with a history of stroke were more likely 
to report breathing pauses. Yaggi and Mohsenin30 showed that 
the presence of OSAHS increases the risk for stroke, while there 
was evidence that sleep apnea is the actual cause of hypertension, 
CVD, stroke, and other medical conditions.31
Despite the useful findings, our results have certain 
limitations. Chronic medical diseases such as history of 
CVDs, hypertension, and stroke were documented from the 
medical files that may not have been sufficiently completed. 
For example, there may have been undiagnosed medical 
conditions that might act as confounders in prevalence of the 
OSAHS-related symptoms. Furthermore, the OSAHS- related 
symptoms might be clustered in subgroups of patients with 
specific airway disease such asthma, COPD, or bronchiectasis. 
However, the underlying airway disease that could be the cause 
of airflow limitation has not been investigated in the present 
study. Another potential limitation of this study is that the 
results were based on self-reports, whereas polysomnography 
was not performed. In addition, spirometry according to the 
American Thoracic Society and European Respiratory Society 
standards cannot be easily performed on our elderly study 
participants. In this study, we often needed more than three 
efforts in order to complete an accepted spirometry test.
Conclusion
Our data suggest that OSAHS-related symptoms are not 
related to airflow limitation for people aged over 65 years old. 
In addition, a lower BMI and advanced age of our sample with 
airflow limitation possibly contributed to decreased frequency of 
OSAHS- related symptoms. However, sleep studies are needed 
to evaluate this assumption. Finally, both airflow limitation and 
OSAHS remain largely undiagnosed in Greek primary care 
settings according to our door-to-door spirometry and OSAHS 
screening program. General Practitioners and health profession-
als in primary care should perform short screening programs for 
OSAHS, focused especially on males and obese populations.
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